News

Filter

Current filters:

None

95995 to 96004 of 97874 results

US HEALTH CARE COMPENDIUM

06-07-1992

Market Intelligence Research Corporation's new 240-page Healthcare Compendium is intended to be the first…

Dainippon phase III trials

06-07-1992

- Dainippon's anti-epileptic compound zonisamide has now entered Phase III clinical trials in the…

ZonegranZonisamide

FRENCH FUNDS' "ARCHAIC METHODS"

06-07-1992

Spending by the French health funds rose to 420 billion French francs ($79.5 billion) in 1990, but the…

good pharma results for UCB: '91

06-07-1992

good 1991 pharma results for UCB

UCB's Pharmaceutical Division showed an increase to 27% of total group…

CetirizineUCBZyrtec

green cross venopirin

06-07-1992

- Green Cross is to withdraw its analgesic product Venopirin (aspirin DL-lysine), from sale in Japan…

AspirinBayer

Sandoz' Sandimmun For Psoriasis

06-07-1992

Sandimmun For Psoriasis In the meantime, Sandoz' UK arm has received approval to market its immunosuppressive…

Sandoz

DEVELOPMENTS AT SOMATOGEN

06-07-1992

Somatogen has begun two new research initiatives that may substantially increase the potential market…

Antihemophilic FactorCoagulation Factor VIIaRecombinant

LILLY SUES OVER CECLOR IN JAPAN

06-07-1992

Eli Lilly is taking six minor Japanese companies to court over their plans to market generic versions…

CeclorCefaclorLillyShionogi

DATABASE AFFIRMS THE SAFETY OF FLUVOXAMINE

06-07-1992

The safety of selective serotonin reuptake inhibitor antidepressants has been the subject of some considerable…

Fluoxetine HclLillyProzacSolvay

95995 to 96004 of 97874 results

COMPANY SPOTLIGHT

Menarini

Back to top